Determinants of specificity for alpha-conotoxin MII on alpha 3 beta 2 neuronal nicotinic receptors

被引:106
作者
Harvey, SC
McIntosh, JM
Cartier, GE
Maddox, FN
Luetje, CW
机构
[1] UNIV MIAMI, SCH MED, DEPT MOL & CELLULAR PHARMACOL, MIAMI, FL 33101 USA
[2] UNIV UTAH, DEPT BIOL, SALT LAKE CITY, UT 84112 USA
[3] UNIV UTAH, DEPT PSYCHIAT, SALT LAKE CITY, UT 84112 USA
关键词
D O I
10.1124/mol.51.2.336
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The competitive antagonist alpha-conotoxin-MII (alpha-CTx-MII) is highly selective for the alpha 3 beta 2 neuronal nicotinic receptor. Other receptor subunit combinations (alpha 2 beta 2, alpha 4 beta 2, alpha 3 beta 4) are >200-fold less sensitive to blockade by this toxin. Using chimeric and mutant subunits, we identified amino acid residues of alpha 3 and beta 2 that participate in determination of alpha-CTx-MII sensitivity. Chimeric alpha subunits, constructed from the alpha 3 and alpha 4 subunits, as well as from the alpha 3 and alpha 2 subunits, were expressed in combination with the beta 2 subunit in Xenopus laevis oocytes. Chimeric beta subunits, formed from the beta 2 and beta 4 subunits, were expressed in combination with alpha 3. Determinants of alpha-CTx-MII sensitivity on alpha 3 were found to be within sequence segments 121-181 and 181-195. The 181-195 segment accounted for approximately half the difference in toxin sensitivity between receptors formed by alpha 2 and alpha 3. When this sequence of alpha 2 was replaced with the corresponding alpha 3 sequence, the resulting chimera formed receptors only 26-fold less sensitive to alpha-CTx-MII than alpha 3 beta 2. Site-directed mutagenesis within segment 181-195 demonstrated that Lys185 and Ile188 are critical in determination of sensitivity to toxin blockade. Determinants of alpha-CTx-MII sensitivity on beta 2 were mapped to sequence segments 1-54, 54-63, and 63-80. Site-directed mutagenesis within segment 54-63 of beta 2 demonstrated that Thr59 is important in determining alpha-CTx-MII sensitivity.
引用
收藏
页码:336 / 342
页数:7
相关论文
共 38 条
  • [1] ABRAMSON SN, 1989, J BIOL CHEM, V264, P12666
  • [2] MOLECULAR-BASIS OF THE 2 NONEQUIVALENT LIGAND-BINDING SITES OF THE MUSCLE NICOTINIC ACETYLCHOLINE-RECEPTOR
    BLOUNT, P
    MERLIE, JP
    [J]. NEURON, 1989, 3 (03) : 349 - 357
  • [3] FUNCTIONAL EXPRESSION OF 2 NEURONAL NICOTINIC ACETYLCHOLINE-RECEPTORS FROM CDNA CLONES IDENTIFIES A GENE FAMILY
    BOULTER, J
    CONNOLLY, J
    DENERIS, E
    GOLDMAN, D
    HEINEMANN, S
    PATRICK, J
    [J]. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1987, 84 (21) : 7763 - 7767
  • [4] Cartier G. E., 1996, Society for Neuroscience Abstracts, V22, P268
  • [5] A new alpha-conotoxin which targets alpha 3 beta 2 nicotinic acetylcholine receptors
    Cartier, GE
    Yoshikami, DJ
    Gray, WR
    Luo, SQ
    Olivera, BM
    McIntosh, JM
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1996, 271 (13) : 7522 - 7528
  • [6] CHIARA D C, 1992, Biophysical Journal, V61, pA106
  • [7] REGIONS OF BETA-2 AND BETA-4 RESPONSIBLE FOR DIFFERENCES BETWEEN THE STEADY-STATE DOSE-RESPONSE RELATIONSHIPS OF THE ALPHA-3-BETA-2 AND ALPHA-3-BETA-4 NEURONAL NICOTINIC RECEPTORS
    COHEN, BN
    FIGL, A
    QUICK, MW
    LABARCA, C
    DAVIDSON, N
    LESTER, HA
    [J]. JOURNAL OF GENERAL PHYSIOLOGY, 1995, 105 (06) : 745 - 764
  • [8] Colquhoun L., 1993, Society for Neuroscience Abstracts, V19, P1533
  • [9] IDENTIFICATION OF A NEW COMPONENT OF THE AGONIST BINDING-SITE OF THE NICOTINIC ALPHA-7 HOMOOLIGOMERIC RECEPTOR
    CORRINGER, PJ
    GALZI, JL
    EISELE, JL
    BERTRAND, S
    CHANGEUX, JP
    BERTRAND, D
    [J]. JOURNAL OF BIOLOGICAL CHEMISTRY, 1995, 270 (20) : 11749 - 11752
  • [10] CZAJKOWSKI C, 1991, J BIOL CHEM, V266, P22603